home / stock / vrna / vrna articles

VRNA Articles, Verona Pharma plc

Stock Information
Company Name: Verona Pharma plc
Stock Symbol: VRNA
Market: NASDAQ
Menu
VRNA VRNA Quote VRNA Short VRNA News VRNA Articles VRNA Message Board
Get VRNA Alerts

News, Short Squeeze, Breakout and More Instantly...
First Inhaled COPD Therapy In Over 2 Decades - FDA Approves Verona Pharma's First Commercial Product | Benzinga

On Wednesday, the FDA approved Verona Pharma plc’s (NASDAQ:VRNA) Ohtuvayre (ensifentrine) for the maintenance treatment of chronic obstructiv...
5 Biotech Stocks With Key Catalysts This Week: Merck, Intellia, Verona, And More | Benzinga

Biotech stocks are high-risk, high-return opportunities that are under the mercy of several make-or-break catalysts, most of which are binary event...

Tesla, Nvidia, John Wiley & Sons And Other Big Stocks Moving Higher On Thursday | Benzinga

U.S. stocks were mixed, with the Dow Jones index falling around 200 points on Thursday. Shares of Tesla Inc (NASDAQ:TSLA) rose sharply during Thurs...

Verona Pharma Announces $650 Million Strategic Financing with Oaktree and OMERS | Benzinga

Non-dilutive funding will support planned US commercial launch and expansion of ensifentrine's clinical activities Cash runway extended beyo...
Verona Pharma to Present Additional Analyses of Positive Phase 3 ENHANCE Studies in COPD at ATS 2024 | Benzinga

PDUFA Target Action Date of June 26, 2024 Eight posters including two oral presentations support potential of ensifentrine,an investigational, fir...

Verona Pharma to Report First Quarter 2024 Financial Results and Provide Corporate Update | Benzinga

LONDON and RALEIGH, N.C., April 25, 2024 (GLOBE NEWSWIRE) -- Verona Pharma plc (NASDAQ:VRNA) ("Verona Pharma" or the "Company") announces that i...

Michael Austwick Joins Verona Pharma as Non-Executive Director | Benzinga

LONDON and RALEIGH, N.C., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Verona Pharma plc (NASDAQ:VRNA) ("Verona Pharma") announces Mr. Michael Austwick has...
Verona Pharma to Present at 42nd Annual J.P. Morgan Healthcare Conference | Benzinga

LONDON and RALEIGH, N.C., Jan. 03, 2024 (GLOBE NEWSWIRE) -- Verona Pharma plc (NASDAQ:VRNA) ("Verona Pharma" or the "Company"), announces that s...

Verona Pharma enters into Debt Facility of up to $400 Million with Oxford Finance and Hercules Capital | Benzinga

LONDON and RALEIGH, N.C., Jan. 02, 2024 (GLOBE NEWSWIRE) -- Verona Pharma plc (NASDAQ:VRNA) ("Verona Pharma"), announces it and its wholly-owned...

Verona Pharma's Promising COPD Treatment Puts It in GSK's Acquisition Crosshairs, Analysts Predict Big Moves | Benzinga

In recent statements to the Financial Times and The Sunday Times, GSK plc (NYSE: GSK) Chief Commercial Officer Luke Miels revealed the co...
Next 10